Skip to main content
SpringerLink
Log in

Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Clozapine has been shown to increase extracellular dopamine (DA) and noradrenaline (NA) in the medial prefrontal cortex (mPFC). A recent study of ours suggested that extracellular DA in the PFC originates not only from dopaminergic but also from noradrenergic terminals, its release being controlled by α2-adrenoceptors.

Objectives

Since clozapine binds to α2-adrenoceptors, the possibility that it might co-release DA and NA was studied.

Methods

By means of microdialysis coupled to HPLC with electrochemical detection, the effect of clozapine on extracellular DA and NA in the mPFC, densely innervated by DA and NA, was compared to that in the occipital cortex, equally innervated by NA but receiving few DA projections.

Results

Extracellular NA was found to be the same in the two cortices, consistent with homogeneous NA innervation. On the other hand, extracellular DA in the occipital cortex was only 29% lower than in the mPFC, in spite of the scarce dopaminergic innervation in the occipital cortex. Clozapine (10 mg/kg IP) increased extracellular DA and NA not only in the mPFC (by about 320% and 290%, respectively) but also in the occipital cortex (by 560% and 230%, respectively). Administration of the α2-agonist clonidine (0.15 mg/kg) reversed the effect of clozapine in both cortices, while the D2-agonist quinpirole (0.1 mg/kg IP) was ineffective.

Conclusions

The results suggest that clozapine, by inhibiting α2-adrenoceptors, co-releases DA and NA from noradrenergic terminals in the occipital cortex and that the same mechanism might be responsible for the concomitant increase of the two monoamines in the mPFC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  • Baldessarini RJ, Frankenburg FR (1991) Clozapine. A novel antipsychotic agent. N Engl J Med 324:746–754

    CAS  PubMed  Google Scholar 

  • Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87–96

    Article  CAS  PubMed  Google Scholar 

  • Carboni E, Tanda GL, Frau R, Di Chiara G (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067–1070

    CAS  PubMed  Google Scholar 

  • Carpenter WT, Magno Zito J, Vitrai J, Volavka J (1998) Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy? Biol Psychiatry 43:79–83

    Article  CAS  PubMed  Google Scholar 

  • Casu MA, Colombo G, Gessa GL, Pani L (2002) Reduced TH-immunoreactive fibers in the limbic system of Sardinian alcohol-preferring rats. Brain Res 924:242–251

    Article  CAS  PubMed  Google Scholar 

  • Chen JP, Ruan D, Paredes W, Gardner EL (1992) Effects of acute and chronic clozapine on dopaminergic function in medial prefrontal cortex of awake, freely moving rats. Brain Res 571:235–241

    CAS  PubMed  Google Scholar 

  • Devoto P, Flore G, Pani L, Gessa GL (2001) Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry 6:657–664

    Article  CAS  PubMed  Google Scholar 

  • Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M (2000) Dissociation of haloperidol, clozapine and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology 22:642–649

    Google Scholar 

  • Gresch PJ, Sved AF, Zigmond MJ, Finlay JM (1995) Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 65:111–116

    CAS  PubMed  Google Scholar 

  • Heidbreder CA, Foxton R, Cilia J, Hughes ZA, Shah AJ, Atkins A, Hunter AJ, Hagan JJ, Jones DNC (2001) Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation. Psychopharmacology 156:338–351

    Google Scholar 

  • Hertel P, Fagerquist MV, Svensson TH (1999a) Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by α2-adrenoceptor blockade. Science 286:105–107

    Article  CAS  PubMed  Google Scholar 

  • Hertel P, Nomikos GG, Svensson TH (1999b) Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level. Eur J Pharmacol 371:153–158

    CAS  PubMed  Google Scholar 

  • Imperato A, Angelucci L (1989) The effect of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats. Psychopharmacol Bull 25:383–389

    Google Scholar 

  • Imperato A, Tanda G, Frau R, Di Chiara G (1987) Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther 245:257–264

    Google Scholar 

  • Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789–796

    CAS  PubMed  Google Scholar 

  • Kuroki T, Meltzer HY, Ichikawa J (1999) Effect of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharmacol Exp Ther 288:774–781

    CAS  PubMed  Google Scholar 

  • Li X-M, Perry KW, Wong DT, Bymaster FP (1998) Olanzapine increases in vivo dopamine and noradrenaline release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 136:153–161

    Article  CAS  PubMed  Google Scholar 

  • Lidow MS, Williams GV, Goldman-Rakic PS (1998) The cerebral cortex: a case for a common site of action of antipsychotics. Trends Pharmacol Sci 19:136–140

    Article  CAS  PubMed  Google Scholar 

  • Lieberman J, Johns C, Cooper T, Pollack S, Kane J (1989) Clozapine pharmacology and tardive dyskinesia. Psychopharmacology 99:S54–59

    Google Scholar 

  • Lindvall O, Björklund A, Divac I (1978) Organization of the catecholamine neurons projecting to the frontal cortex in the rat. Brain Res 142:1–24

    CAS  PubMed  Google Scholar 

  • Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2:19–76

    CAS  PubMed  Google Scholar 

  • Moghaddam B, Bunney BS (1990) Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem 54:1755–1760

    CAS  PubMed  Google Scholar 

  • Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mice lines. J Neurosci 22:389–395

    CAS  PubMed  Google Scholar 

  • Nutt DJ, Lalies MD, Lione LA, Hudson AL (1997) Noradrenergic mechanism in the prefrontal cortex. J Psychopharmacol 11:163–168

    Google Scholar 

  • Paxinos G, Watson C (1997) The rat brain in stereotaxic co-ordinates. Academic Press, New York

  • Pehek EA, Yamamoto BK (1994) Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J Neurochem 63:2118–2124

    PubMed  Google Scholar 

  • Ramirez OA, Wang RY (1986) Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine. Brain Res 362:165–170

    CAS  PubMed  Google Scholar 

  • Smiley JF, Levey AI, Ciliax BJ, Goldman-Rakic PS (1994) D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci USA 91:5720–5724

    Google Scholar 

  • Souto M, Monti JM, Altier H (1979) Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons. Pharmacol Biochem Behav 10:5–9

    Article  CAS  PubMed  Google Scholar 

  • Sulser F, Vetulani F, Mobley P (1978) Mode of action of antidepressant drugs. Biochem Pharmacol 27:257–261

    Google Scholar 

  • Svensson TH, Bunney BS, Aghajanian GK (1975) Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res 92:291–306

    CAS  PubMed  Google Scholar 

  • Westerink BHC, de Boer P, de Vries JB, Kruse CG, Long SK (1998) Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain. Eur J Pharmacol 361:27–33

    CAS  PubMed  Google Scholar 

  • White FJ, Wang RY (1984) Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. J Pharmacol Exp Ther 231: 275–280

    CAS  PubMed  Google Scholar 

  • Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376:572–575

    CAS  PubMed  Google Scholar 

  • Yamamoto BK, Novotney S (1998) Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 71:274–280

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. "B.B. Brodie" Department of Neuroscience, University of Cagliari, Cittadella Universitaria, SS 554 km 4.500, 09042 , Monserrato, Italy

    Paola Devoto, Giovanna Flore, Giada Vacca, Alessandra Arca & Gian Luigi Gessa

  2. Center of Excellence "Neurobiology of Addiction", University of Cagliari, Italy

    Paola Devoto & Gian Luigi Gessa

  3. Neuroscienze SCaRL, Cagliari, Italy

    Luigi Pira, Maria Antonietta Casu, Luca Pani & Gian Luigi Gessa

  4. Institute of Neurogenetic and Neuropharmacology, C.N.R., Cagliari, Italy

    Luca Pani

Authors
  1. Paola Devoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanna Flore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giada Vacca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luigi Pira
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alessandra Arca
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maria Antonietta Casu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Luca Pani
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gian Luigi Gessa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paola Devoto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Devoto, P., Flore, G., Vacca, G. et al. Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacology 167, 79–84 (2003). https://doi.org/10.1007/s00213-002-1381-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-002-1381-y

Keywords

Search

Navigation